MOG and myeloid sarcoma: When actively immunized with myelin oligodendrocyte glycoprotein (MOG)[35−55], non-obese diabetic (NOD) background mice present a relatively slow-developing disease over 70–100 days that is characterized by multiple relapses and remissions followed by chronically worsening symptoms, thus recapitulating the most common form of MS.